148 related articles for article (PubMed ID: 2899720)
1. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.
O'Grady JG; Alexander GJ; Sutherland S; Donaldson PT; Harvey F; Portmann B; Calne RY; Williams R
Lancet; 1988 Aug; 2(8606):302-5. PubMed ID: 2899720
[TBL] [Abstract][Full Text] [Related]
2. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
[TBL] [Abstract][Full Text] [Related]
3. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation.
Paya CV; Wiesner RH; Hermans PE; Larson-Keller JJ; Ilstrup DM; Krom RA; Moore SB; Ludwig J; Smith TF
Hepatology; 1992 Jul; 16(1):66-70. PubMed ID: 1319956
[TBL] [Abstract][Full Text] [Related]
4. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
[TBL] [Abstract][Full Text] [Related]
5. Cytomegalovirus infection in renal transplant recipients: one center's experience.
Bal Z; Uyar ME; Tutal E; Erdogan E; Colak T; Sezer S; Haberal M
Transplant Proc; 2013; 45(10):3520-3. PubMed ID: 24314948
[TBL] [Abstract][Full Text] [Related]
6. Effects of donor/recipient human leukocyte antigen mismatch on human cytomegalovirus replication following liver transplantation.
Aldridge RW; Mattes FM; Rolando N; Rolles K; Smith C; Shirling G; Atkinson C; Burroughs AK; Milne RS; Emery VC; Griffiths PD
Transpl Infect Dis; 2015 Feb; 17(1):25-32. PubMed ID: 25572799
[TBL] [Abstract][Full Text] [Related]
7. Relationship between HLA tissue type, CMV infection, and acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation: single-center experience.
Kekik C; Besisik SK; Seyhun Y; Oguz FS; Sargin D; Carin MN
Transplant Proc; 2009 Nov; 41(9):3859-62. PubMed ID: 19917401
[TBL] [Abstract][Full Text] [Related]
8. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
[TBL] [Abstract][Full Text] [Related]
9. Hepatic alpha-interferon expression in cytomegalovirus-infected liver allograft recipients with and without vanishing bile duct syndrome.
Arnold JC; Nouri-Aria KT; O'Grady JG; Portmann BC; Alexander GJ; Williams R
Clin Investig; 1993 Mar; 71(3):191-6. PubMed ID: 8386961
[TBL] [Abstract][Full Text] [Related]
10. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation.
Hoffmann RM; Günther C; Diepolder HM; Zachoval R; Eissner HJ; Forst H; Anthuber M; Paumgartner G; Pape GR
Transpl Int; 1995; 8(5):353-9. PubMed ID: 7576016
[TBL] [Abstract][Full Text] [Related]
12. [Influence of HLA compatibility on cytomegalovirus infection in kidney transplantation].
Pouteil-Noble C; Bétuel H; Raffaele P; Megri K; Louvier C; Lefrançois N; Bosshard S; Dubernard JM; Aymard M; Touraine JL
Presse Med; 1991 Nov; 20(40):2022-4. PubMed ID: 1662376
[TBL] [Abstract][Full Text] [Related]
13. Sex mismatch as a risk factor for chronic rejection of liver allografts.
Candinas D; Gunson BK; Nightingale P; Hubscher S; McMaster P; Neuberger JM
Lancet; 1995 Oct; 346(8983):1117-21. PubMed ID: 7475600
[TBL] [Abstract][Full Text] [Related]
14. Persistent cytomegalovirus in liver allografts with chronic rejection.
Lautenschlager I; Höckerstedt K; Jalanko H; Loginov R; Salmela K; Taskinen E; Ahonen J
Hepatology; 1997 Jan; 25(1):190-4. PubMed ID: 8985289
[TBL] [Abstract][Full Text] [Related]
15. Influence of positive lymphocyte crossmatch and HLA mismatching on vanishing bile duct syndrome in human liver allografts.
Batts KP; Moore SB; Perkins JD; Wiesner RH; Grambsch PM; Krom RA
Transplantation; 1988 Feb; 45(2):376-9. PubMed ID: 3278430
[TBL] [Abstract][Full Text] [Related]
16. An association between cytomegalovirus infection and chronic rejection after liver transplantation.
Evans PC; Soin A; Wreghitt TG; Taylor CJ; Wight DG; Alexander GJ
Transplantation; 2000 Jan; 69(1):30-5. PubMed ID: 10653376
[TBL] [Abstract][Full Text] [Related]
17. Evidence for an immune response to HLA class I antigens in the vanishing-bileduct syndrome after liver transplantation.
Donaldson PT; Alexander GJ; O'Grady J; Neuberger J; Portmann B; Thick M; Davis H; Calne RY; Williams R
Lancet; 1987 Apr; 1(8539):945-51. PubMed ID: 2882341
[TBL] [Abstract][Full Text] [Related]
18. Role of Human Leukocyte Antigen Compatibility in Graft Outcomes After Living Donor Liver Transplantation.
Shin M; Kim JM; Kwon CH; Kim SJ; Joh JW
Transplant Proc; 2016 May; 48(4):1123-9. PubMed ID: 27320571
[TBL] [Abstract][Full Text] [Related]
19. Cytomegalovirus infection is associated with increased inflammation and severe bile duct damage in rat liver allografts.
Martelius T; Krogerus L; Höckerstedt K; Bruggeman C; Lautenschlager I
Hepatology; 1998 Apr; 27(4):996-1002. PubMed ID: 9537439
[TBL] [Abstract][Full Text] [Related]
20. Association of human cytomegalovirus viremia with human leukocyte antigens in liver transplantation recipients.
Hu J; Meng X; Zhao H; Zhang X; Gao H; Yang M; Ma Y; Li M; Ma W; Fan J
Acta Biochim Biophys Sin (Shanghai); 2011 Jul; 43(7):576-81. PubMed ID: 21680603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
